Then, the lower levels of HRH1 observed in AML and MDS could be related to the low levels of HRH1 seen in HSCs and non‐myeloid blood cells, as previously reported (Figure 1A).2 This evidence concerns the gene HRH1 and acute myeloid leukemia.